FERMENTA BIOTECH LIMITED — M&A Activity 2023

Feb 24, 2023

==> picture [449 x 64] intentionally omitted <==

Date: February 24, 2023

The Manager, The Corporate Relationship Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai – 400001

Scrip Code: 506414

Dear Sir / Madam,

Ref: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

• Sub: Intimation regarding the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited (“Transferor Company 1”) and Aegean Properties Limited (“Transferor Company 2”) and Fermenta Biotech Limited (“Transferee Company”) and their respective Shareholders, under sections 230 to 232 of the Companies Act, 2013 (“Scheme”) filed before the Hon’ble National Company Law Tribunal, Mumbai Bench.

With reference to the captioned subject, we would like to inform you that our matter was listed today for final hearing. We are pleased to inform you that our matter was heard by the National Company Law Tribunal, Mumbai Bench (“NCLT”). However, we await the further instructions from Hon’ble NCLT in this regard.

We request you to kindly take the above information on record.

Thanking you.

Yours faithfully,

For Fermenta Biotech Limited

SRIKANT NATH Digitally signed by SRIKANT NATH SHARMA SHARMA Date: 2023.02.24 16:44:24 +05'30'

Srikant N. Sharma Company Secretary

==> picture [448 x 62] intentionally omitted <==